medigraphic.com
SPANISH

Revista Mexicana de Urología

Organo Oficial de la Sociedad Mexicana de Urología
  • Contents
  • View Archive
  • Information
    • General Information        
    • Directory
  • Publish
    • Authors instructions        
  • medigraphic.com
    • Home
    • Journals index            
    • Register / Login
  • Mi perfil

2018, Number 5

Rev Mex Urol 2018; 78 (5)

Treatment of a fatty tumor thrombus in the renal vein extending into the vena cava: Presentation of two cases

Antón-Juanilla M, Arruza-Echeverría A
Full text How to cite this article

Language: Spanish
References: 7
Page: 379-384
PDF size: 349.54 Kb.


Key words:

Thrombus, Renal vein, Angiomyolipoma, Anticoagulants, Vena cava, Embolism.

ABSTRACT

Background: A fatty tumor thrombus in the renal vein is rare and angiomyolipoma is the only benign tumor associated with it.
Clinical cases: Case 1: a 70-year-old woman presented with the incidental finding of a fatty tumor thrombus, during endocrine follow-up, in the left renal vein that extended into the vena cava, with no clearly associated kidney lesion. She was managed conservatively with anticoagulation and yearly control. Case 2: a 43-year-old woman was diagnosed during pregnancy with a mass in the right renal sinus, with a fatty thrombus in the renal vein and vena cava. Anticoagulation was begun and in the postpartum period, she underwent a right radical nephrectomy with thrombectomy. The anatomopathologic diagnosis was angiomyolipoma.
Conclusions: A fatty tumor thrombus in the renal vein is rare and usually linked to a renal angiomyolipoma. Due to the risk for pulmonary embolism or malignant differentiation, radical nephrectomy with thrombectomy is the indicated treatment, even in asymptomatic patients. In the case of an isolated fatty thrombus in patients with comorbidities, conservative treatment is a valid option.


REFERENCES

  1. Fittschen A, et al. Prevalence of sporadic renal angiomyolipoma: a retrospective analysis of 61,389 in- and outpatients. Abdom Imaging 2014;39(5):1009-13. https://doi. org/10.1007/s00261-014-0129-6

  2. Seyam RM, et al. The risks of renal angiomyolipoma: reviewing the evidence. J Kidney Cancer VHL 2017; 4(4):13- 25. http://dx.doi.org/10.15586/jkcvhl.2017.97

  3. Kutikov A, et al. The R.E.N.A.L. Nephrometry Score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J Urol. 2009; 182:844-53. https://doi.org/10.1016/j.juro.2009.05.035

  4. Raft J, et al. Influence of pregnancy on renal angiomyolipoma. Gynecol Obstet Fertil 2005; 33:898-906. https://doi. org/10.1016/j.gyobfe.2005.09.015

  5. Rothberg G, et al. Rapid growth of a kidney angiomyolipoma after initiation of oral contraceptive therapy. Obstet Gynecol 2006; 108:734-6. doi: 10.1097/01. AOG.0000188062.13749.ef

  6. Lopater J, et al. Management of angiomyolipoma vena cava thrombus during pregnancy. Obstet Gynecol. 2011; February;117(2 Pt 2):440–3. doi: 10.1097/ AOG.0b013e3181edbc56

  7. Xiang L, et al. Malignant epithelioid angiomyolipoma invading the inferior vena cava: using a temporary vena cava filter to prevent tumour emboli during nephrectomy. Can Urol Assoc J. 2014 Jul-Aug; 8(7-8): E564-E566. http:// dx.doi.org/10.5489/cuaj.1814




2020     |     www.medigraphic.com

Mi perfil

CÓMO CITAR (Vancouver)

Rev Mex Urol. 2018;78